Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...

The number of voluntary donors decreases as many exceed the age limit of 65 years and are not replaced by younger people.

Takeda’s plasma-derived therapies (PDT) business tackles supply-chain challenges to expand access to life-saving treatments, ...